Johnson & Johnson Rule 144 Notice — 16,820 Shares via Fidelity on NYSE

Rhea-AI Filing Summary

Form 144 notice for Johnson & Johnson (JNJ): The filing reports a proposed sale of 16,820 shares of common stock through Fidelity Brokerage Services LLC on the NYSE with an approximate sale date of 08/15/2025. The filing lists an aggregate market value of $2,975,571.23 for the shares and shows 2,408,338,872 shares outstanding. The securities were acquired under options granted on 02/08/2016, the purchaser is listed as the issuer, and the indicated form of payment is cash. The filer certifies they have no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider/affiliate notice to sell shares under Rule 144; size is small relative to outstanding shares.

The Form 144 documents a proposed public sale of 16,820 JNJ common shares via Fidelity on 08/15/2025 with an aggregate value of about $2.98 million. The securities are tied to options granted 02/08/2016 and payment is in cash. This filing is procedural under Rule 144 and does not disclose new operational or financial information about the issuer. From an investor-impact perspective, the reported sale amount is immaterial relative to the company's large share count, and no recent sales in the prior three months are reported.

Corporate Governance Expert

TL;DR: Compliance disclosure indicating an intended sale; confirms signer attests no undisclosed material information.

The notice fulfills Rule 144 disclosure requirements for an affiliate or insider disposing of securities. It identifies the broker, the number of shares, acquisition source (options granted in 2016), and payment method. The filing includes the standard signature representation about absence of undisclosed material adverse information. There are no governance red flags or extraordinary transactions disclosed in this submission.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	16820	2975571.23	2408338872	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Options Granted 02/08/2016	Issuer			16820	08/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the JNJ Form 144 report?

The filing reports a proposed sale of 16,820 JNJ common shares on 08/15/2025 through Fidelity Brokerage Services LLC on the NYSE with an aggregate market value of $2,975,571.23.

How were the securities acquired according to the Form 144?

The securities were acquired via options granted on 02/08/2016, listed as acquired from the issuer.

What payment method is indicated for the sale in the filing?

The filing indicates cash as the nature of payment for the securities.

Does the filing report any other sales by the seller in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

How many JNJ shares are outstanding according to the Form 144?

The filing shows 2,408,338,872 shares outstanding.